Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
This paper introduces CompressedMediQ, a novel hybrid quantum-classical machine learning pipeline specifically developed to address the computational challenges associated with high-dimensional multi-class neuroimaging data analysis. Standard neuroimaging datasets, such as large-scale MRI data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) and Neuroimaging in Frontotemporal Dementia...
Alzheimer's disease (AD) is a neurodegenerative disorder marked by memory loss and cognitive decline, making early detection vital for timely intervention. However, early diagnosis is challenging due to the heterogeneous presentation of symptoms. Resting-state functional magnetic resonance imaging (rs-fMRI) captures spontaneous brain activity and functional connectivity, which are known to be di...
Based on official estimates, 50 million people worldwide are affected by dementia, and this number increases by 10 million new patients every year. ...
Neurodegenerative dementia syndromes, such as primary progressive aphasias (PPA), have traditionally been diagnosed based, in part, on verbal and non-...
Neuropathological diagnosis of Alzheimer disease (AD) relies on semiquantitative analysis of phosphorylated tau-positive neurofibrillary tangles (NFTs...
Large Language Models (LLMs) stand on the brink of reshaping the field of aging and dementia care, challenging the one-size-fits-all paradigm with the...
We applied natural language processing (NLP) to a corpus extracted from 4 hours of expert panel discussion transcripts to determine the sustainability...
The population of dementia patients is on the rise, as society undergoes rapid aging. This led to an expansion of dementia-related data. This study ai...
This study investigates the causal relationships between Clinical Dementia Ratings (CDR) and its six domain scores across two distinct aging dataset...
With the increasing number of patients diagnosed with Alzheimer's Disease, prognosis models have the potential to aid in early disease detection. Ho...
MEG are non invasive neuroimaging techniques with excellent temporal and spatial resolution, crucial for studying brain function in dementia and Alz...
Deep Learning (DL) in neuroimaging has become increasingly relevant for detecting neurological conditions and neurodegenerative disorders. One of th...
Vision--Language Models (VLMs) have demonstrated success across diverse applications, yet their potential to assist in relevance judgments remains u...
Alzheimer's disease (AD) progresses from asymptomatic changes to clinical symptoms, emphasizing the importance of early detection for proper treatme...
PURPOSE: Changes in retinal structure and microvasculature are connected to parallel changes in the brain. Two recent studies described machine learni...
In recent years, brain imaging genomics has advanced significantly in revealing underlying pathological mechanisms of Alzheimer's disease (AD) and pro...
Time series from different regions of interest (ROI) of default mode network (DMN) from Functional Magnetic Resonance Imaging (fMRI) can reveal sign...
State-space models (SSMs) have garnered attention for effectively processing long data sequences, reducing the need to segment time series into shor...
Plasma protein biomarkers have been considered promising tools for diagnosing dementia subtypes due to their low variability, cost-effectiveness, and ...
Rapid advances in artificial intelligence (AI) have reshaped healthcare, including psychiatric nursing, to address the limitations of traditional appr...